Biodefence

Biodefence refers to the preparedness and response framework designed to prevent, detect, and mitigate biological threats, including naturally occurring outbreaks, accidental releases, and deliberate biological attacks. This field encompasses development of vaccines, therapeutics, diagnostics, and surveillance systems that protect public health and national security. Biodefence programmes often prioritise rapid response capabilities, scalable manufacturing, and stockpiling strategies for high consequence pathogens.

The biopharmaceutical industry plays a central role in biodefence through research and development of medical countermeasures, often supported by government funding and strategic partnerships. Manufacturers build flexible platforms capable of rapidly producing vaccines or antiviral therapies in response to emerging threats. Regulatory agencies provide emergency pathways and guidance to accelerate availability of critical interventions while maintaining safety standards. As global health risks evolve, biodefence efforts increasingly focus on platform technologies, supply chain resilience, and rapid clinical evaluation strategies that enable timely protection of populations against biological emergencies.